ATE310100T1 - Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität - Google Patents

Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität

Info

Publication number
ATE310100T1
ATE310100T1 AT01940552T AT01940552T ATE310100T1 AT E310100 T1 ATE310100 T1 AT E310100T1 AT 01940552 T AT01940552 T AT 01940552T AT 01940552 T AT01940552 T AT 01940552T AT E310100 T1 ATE310100 T1 AT E310100T1
Authority
AT
Austria
Prior art keywords
modulators
methyltransferase
suv39h2
screening method
chromosome stability
Prior art date
Application number
AT01940552T
Other languages
English (en)
Inventor
Thomas Jenuwein
Stephen Rea
Frank Eisenhaber
Donal O'carroll
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00112479A external-priority patent/EP1162460A1/de
Priority claimed from EP00112345A external-priority patent/EP1162274A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE310100T1 publication Critical patent/ATE310100T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
    • G01N2333/91011—Methyltransferases (general) (2.1.1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01940552T 2000-06-09 2001-06-07 Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität ATE310100T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00112479A EP1162460A1 (de) 2000-06-09 2000-06-09 Screeningverfahren für Modulatoren des Suv39h2 Methyltransferases und der männlichen Gametogenese
EP00112345A EP1162274A1 (de) 2000-06-09 2000-06-09 Verfahren zur Identifizierung von Verbindungen, die die Methyltransferase-abhängige Chromosomen-Stabilität beeinflussen
PCT/EP2001/006485 WO2001094620A1 (en) 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability

Publications (1)

Publication Number Publication Date
ATE310100T1 true ATE310100T1 (de) 2005-12-15

Family

ID=26071033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940552T ATE310100T1 (de) 2000-06-09 2001-06-07 Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität

Country Status (7)

Country Link
EP (2) EP1294927B1 (de)
JP (2) JP4896344B2 (de)
AT (1) ATE310100T1 (de)
AU (2) AU2001274088A1 (de)
DE (1) DE60115039T2 (de)
ES (1) ES2252240T3 (de)
WO (2) WO2001094620A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106152A1 (en) * 2001-12-27 2005-05-19 Yuichi Hikichi Preventives/remedies for cancer
GB0301450D0 (en) * 2003-01-22 2003-02-19 Medical Res Council Protein crystal structure
JP3913181B2 (ja) * 2003-02-06 2007-05-09 三菱重工業株式会社 カーボンナノファイバの製造方法及び製造装置
WO2008114709A1 (ja) * 2007-03-15 2008-09-25 Reverse Proteomics Research Institute Co., Ltd. 血球系に特異的あるいは破骨細胞分化に特異的なバイオマーカー
EP2714903B1 (de) * 2011-06-03 2018-03-21 OncoTherapy Science, Inc. Suv39h2 als zielgen für krebstherapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU751784B2 (en) * 1997-08-29 2002-08-29 Innogenetics N.V. Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus

Also Published As

Publication number Publication date
JP4896344B2 (ja) 2012-03-14
ES2252240T3 (es) 2006-05-16
AU2001274088A1 (en) 2001-12-17
JP2003535595A (ja) 2003-12-02
DE60115039T2 (de) 2006-07-27
JP2003535596A (ja) 2003-12-02
EP1294927B1 (de) 2005-11-16
EP1294927A1 (de) 2003-03-26
DE60115039D1 (de) 2005-12-22
WO2001094621A1 (en) 2001-12-13
EP1294928A1 (de) 2003-03-26
AU2001266055A1 (en) 2001-12-17
WO2001094620A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
NO985376D0 (no) Kinolinkarboksamider som TNF-inhibitorer og som PDA-IV inhibitorer
EP1131333A4 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
ATE288749T1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
BRPI0412845A (pt) herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo
BR9915940A (pt) Métodos e composições para restaurar a estabilidade conformacional de uma proteìna da famìlia p53
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
ES2114786B1 (es) Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion.
DE69733605D1 (de) In vivo gentransfermethoden zur wundheilung
EP1578366A4 (de) Moleküle, die bevorzugt miteffektor-t-zellen oder regulatorischen t-zellen assoziiert sind undanwendungsverfahren dafür
EP0871645A4 (de) Vorrichtung und verfahren zur geteilten behandlung von abwasser
BR9405884A (pt) Disposição de eletrodos para processos eletroliticos com formação de gás em células de membraba e sua utilização
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE340257T1 (de) Histonedeacetylase 9
DE60115039D1 (de) Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE404662T1 (de) Verwendung von zytokinen und mitogenen zur inhibierung von pathologischen immunantworten
DE69734586D1 (de) Retinoid-metabolisierendes protein
DK0750637T3 (da) CAI resistens, som koder for et protein, samt anvendelse deraf
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung
NO971553L (no) Cytoplasmisk tyrosinkinase
BR0214288A (pt) Anticorpos monoclonais especìficos para tumor, ácidos nucléicos que codificam tais anticorpos e método para redução de proliferação de células neoplásicas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1294927

Country of ref document: EP